Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / COM
-
Number of holders
-
16
-
Total 13F shares, excl. options
-
610K
-
Shares change
-
-231K
-
Total reported value, excl. options
-
$1.21M
-
Value change
-
-$389K
-
Number of buys
-
3
-
Number of sells
-
-7
-
Price
-
$2.00
Significant Holders of CytoDyn Inc. - COM (CYDY) as of Q3 2021
20 filings reported holding CYDY - CytoDyn Inc. - COM as of Q3 2021.
CytoDyn Inc. - COM (CYDY) has 16 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 610K shares
.
Largest 10 shareholders include Firsthand Capital Management, Inc. (223K shares), Capital Advantage, Inc. (91K shares), L & S Advisors Inc (50.6K shares), Diversified Trust Co (45.8K shares), Next Capital Management LLC (37.5K shares), CAPTRUST FINANCIAL ADVISORS (28.6K shares), Moloney Securities Asset Management, LLC (27K shares), MAI Capital Management (25K shares), S.A. Mason LLC (19K shares), and HOLLENCREST CAPITAL MANAGEMENT (17K shares).
This table shows the top 16 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.